Industry
From U.S. (Toll Free) : +16467917070    |   UK : +442030260021     |    sales@businessmarketinsights.com

North America Medication Adherence Packaging Market to 2027 - Regional Analysis and Forecasts by System (Unit-Dose Packaging Systems, Multi-Dose Packaging Systems); Type (Ampoules, Blister, Vials, Prefilled Syringes and Injectable, Others); Materials (Plastics, Aluminium, Glass, Paper and Paperboard); and Country

Report Code :  TIPRE00006681
No. of Pages :  128
Published Month :  Sep 2019
Category :  Life Sciences
$299 per month

Best Plan
  • All Reports in One Industry
  • All Reports Read Access
  • Subscription Duration : 12 Months
  • Monthly New Reports Added
  • $1200 Yearly Saving

The North America Medication Adherence Packaging market is to reach US$ 518.78 Mn in 2027 from US$ 304.78 Mn in 2018. The market is estimated to grow with a CAGR of 6.3% from 2019-2027.

The market of medication adherence packaging is estimated to grow due to key driving factors such as rising demand for medication adherence packaging, growing prevalence of chronic diseases and increasing government initiatives. Whereas, the market is likely to experience restraining factors such as high cost of installation and maintenance of medication adherence packaging systems which is likely to slower down the growth of market.

 

In North America, there has been rising burden of medication non-adherence (MNA) on healthcare system. According to the World Health Organization (WHO), medication non-adherence is the major clinical problem in chronic disease management. Rates of non-adherence with any medication vary at an average of 50%. Nearly US$ 213 Bn considered wasteful and avoidable. About US$ 105.4 billion per year, results from medication non-adherence to treat chronic diseases. Diabetes is the second-largest contributor, accounting for US$ 24.6 billion. Conditions such as cardiovascular disease and other diabetes-related complications are not considered in this. Non-adherence of a patient to the prescribed medications is placing a huge burden on the patient and the country’s healthcare system.

In 2012, in the US, it was estimated medication non-adherence causes 125,000 deaths and 10% of hospitalizations which costs approximately US$ 528 Billion.

Around half of the patients with type 2 diabetes in their first year of therapy fail to take at least 80% of prescribed medication. Around US$ 65,464 all-cause cost can be saved on each 1% rise in medication adherence among 1000 patients with diabetes.

 

The chronic nature and lifelong dependency on medication of diabetes pose an important challenge for patients and the provider. Recent advancements in medication adherence technology are also helping to ease the burden associated with non-adherence.

 

US Medication Adherence Packaging Market Revenue and Forecasts to 2027 (US$ Mn)


  

NORTH AMERICA MEDICATION ADHERENCE PACKAGING – MARKET SEGMENTATION

 

North America Medication Adherence Packaging Market – By System

  • Unit-Dose Packaging Systems
  • Multi-Dose Packaging Systems

North America Medication Adherence Packaging Market – By Type

  • Blister
  • Prefilled Syringes and Injectable
  • Vials
  • Ampoules
  • Others

North America Medication Adherence Packaging Market – By Materials

  • Plastics
  • Aluminium
  • Glass
  • Paper and Paperboard

North America Medication Adherence Packaging Market – By Country

  • US
  • Canada
  • Mexico

Company Profiles

  • McKesson Corporation
  • Genoa
  • WestRock Company
  • Catalyst Healthcare Ltd.
  • Omnicell, Inc.
  • TCGRx (Parata Systems)
  • Swisslog Holding AG (Talyst, LLC.)
  • RxSafe, LLC
  • Cardinal Health, Inc.
  • Accu-Chart Plus

 

The List of Companies

 

  1. McKesson Corporation
  2. Genoa
  3. WestRock Company
  4. Catalyst Healthcare Ltd.
  5. Omnicell, Inc.
  6. TCGRx (Parata Systems)
  7. Swisslog Holding AG (Talyst, LLC.)
  8. RxSafe, LLC
  9. Cardinal Health, Inc.
  10. Accu-Chart Plus